A fluorescence anisotropy-based competition assay to identify inhibitors against ricin and Shiga toxin ribosome interactions
Analytical Biochemistry · 2024
DOI: 10.1016/j.ab.2024.115580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Biochemistry, 2024. Verfasst von Arkajyoti Dutta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plant Biology, Rutgers, The State University of New Jersey, 59 Dudley Road, New Brunswick, NJ, 08901, USA. Hauptthemen laut MEDLINE: Ricin, Fluorescence Polarization, Ribosomes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, National Institute of Allergy and Infectious Diseases Division of Intramural Research.
Abstract (Originalsprache)
Ricin is one of the most toxic substances known and a type B biothreat agent. Shiga toxins (Stxs) produced by E. coli (STEC) and Shigella dysenteriae are foodborne pathogens. There is no effective therapy against ricin or STEC and there is an urgent need for inhibitors. Ricin toxin A subunit (RTA) and A1 subunit of Stx2a (Stx2A1) bind to the C-terminal domain (CTD) of the ribosomal P-stalk proteins to depurinate the sarcin/ricin loop. Modulation of toxin-ribosome interactions has not been explored as a strategy for inhibition. Therefore, development of assays that detect inhibitors targeting toxin-ribosome interactions remains a critical need. Here we describe a fluorescence anisotropy (FA)-based competitive binding assay using a BODIPY-TMR labeled 11-mer peptide (P11) derived from the P-stalk CTD to measure the binding affinity of peptides ranging from 3 to 11 amino acids for the P-stalk pocket of RTA and Stx2A1. Comparison of the affinity with the surface plasmon resonance (SPR) assay indicated that although the rank order was the same by both methods, the FA assay could differentiate better between peptides that show nonspecific interactions by SPR. The FA assay detects only interactions that compete with the labeled P11 and can validate inhibitor specificity and mechanism of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plant Biology, Rutgers, The State University of New Jersey, 59 Dudley Road, New Brunswick, NJ, 08901, USA.
- Molecular Design and Synthesis Core, Rutgers University Biomolecular Innovations Cores, Office for Research, Rutgers University, 610 Taylor Rd, Piscataway, NJ, 08854, USA.
- Department of Plant Biology, Rutgers, The State University of New Jersey, 59 Dudley Road, New Brunswick, NJ, 08901, USA. Electronic address: xpli@sebs.rutgers.edu.
- Molecular Design and Synthesis Core, Rutgers University Biomolecular Innovations Cores, Office for Research, Rutgers University, 610 Taylor Rd, Piscataway, NJ, 08854, USA. Electronic address: tumer@sebs.rutgers.edu.
Förderung
- NIAID NIH HHS
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases Division of Intramural Research
- National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases
Zitieren
APA
Dutta, A., Szekely, Z., Guven, H., Li, X. P., McLaughlin, J. E., & Tumer, N. E. (2024). A fluorescence anisotropy-based competition assay to identify inhibitors against ricin and Shiga toxin ribosome interactions. Analytical Biochemistry. https://doi.org/10.1016/j.ab.2024.115580
Vancouver
Dutta A, Szekely Z, Guven H, Li XP, McLaughlin JE, Tumer NE. A fluorescence anisotropy-based competition assay to identify inhibitors against ricin and Shiga toxin ribosome interactions. Analytical Biochemistry. 2024. doi:10.1016/j.ab.2024.115580
BibTeX
@article{Dutta2024,
author = {Dutta, Arkajyoti and Szekely, Zoltan and Guven, Hakan and Li, Xiao-Ping and McLaughlin, John E and Tumer, Nilgun E},
title = {A fluorescence anisotropy-based competition assay to identify inhibitors against ricin and Shiga toxin ribosome interactions},
journal = {Analytical Biochemistry},
year = {2024},
doi = {10.1016/j.ab.2024.115580}
}
EUVIMED